Background illustration for clinical trials search

Paid Clinical Trials Arkansas

Discover 625 paid clinical trials in Arkansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Bangor ME, Scarborough ME, Providence RI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Halifax, Boston MA, Lebanon NH, The Bronx NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

Impact of the Enhanced Recovery After Surgery System for Colorectal Surgery

for
ColoRectal Cancer and Inflammatory Bowel Disease
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT02997293

Recruiting

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Boston MA, Saint Johnsbury VT, Lebanon NH, The Bronx NY,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT06532279

Phase 2, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: Hackensack NJ, Fairfax VA, Toronto, Brampton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

for
B Acute Lymphoblastic Leukemia
Location: Halifax, Scarborough ME, Boston MA, Providence RI,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 46

Code: NCT06124157

Phase 2, Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

for
Recurrent Langerhans Cell Histiocytosis,
Location: Halifax, Hartford CT, New Haven CT, Quebec, Sherbrooke,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 22

Code: NCT05828069

Phase 2, Recruiting

A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema

for
Eczema
Location: Charleston SC, Jacksonville FL, Greenville SC,
Sponsor: Pfizer

Sex: All

Age: 6 - 11

Code: NCT06807268

Phase 3, Recruiting

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

for
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
Location: Togus ME, Boston MA, Providence RI, New Haven CT,
Sponsor: Duke University

Sex: All

Age: 70+

Code: NCT04262206

Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

for
Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma
Location: The Bronx NY, New Brunswick NJ, Hershey PA,
Sponsor: UroGen Pharma Ltd.

Sex: All

Age: 18+

Code: NCT06774131

Phase 3, Recruiting

A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)

for
Lymphoma, Large B-Cell, Diffuse
Location: Boston MA, Westbury NY, Mineola NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06890884

Phase 2, Recruiting

In Vivo Real-time Detection of Circulating Melanoma Cells

for
Melanoma
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18 - 70+

Code: NCT01776905

Recruiting

Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)

for
Von Willebrand Disease (VWD)
Location: New Haven CT, Morrisville NC, Pittsburgh PA, Atlanta GA,
Sponsor: Vega Therapeutics, Inc

Sex: All

Age: 12 - 70+

Code: NCT07115004

Phase 3, Recruiting

Time Restricted Feeding, Muscle, and Metabolism

for
Overweight, Obesity
Location: Fayetteville AR
Sponsor: University of Arkansas, Fayetteville

Sex: All

Age: 25 - 50

Code: NCT04949451

Recruiting

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

for
Head and Neck Squamous Cell Carcinoma,
Location: Damariscotta ME, Bath ME, Augusta ME, Brunswick ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06992427

Phase 3, Recruiting

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

for
Low-grade NMIBC, FGFR Gene Amplification, FGFR Gene Alterations,
Location: Plymouth MA, Astoria NY, The Bronx NY, New York NY,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT06995677

Phase 2, Recruiting

Delivering HOPE (Helping Women Optimize Prenatal Equity)

for
Gestational Weight Gain, Diet, Healthy,
Location: West Memphis AR, Corning AR, Marianna AR, Monticello AR,
Sponsor: University of Arkansas

Sex: Female

Age: 16 - 44

Code: NCT06814509

Recruiting

Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment

for
Substance Use Treatment, Perinatal Substance Use, Parenting
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: Female

Age: 18+

Code: NCT07071766

Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

for
Complex Regional Pain Syndrome Type I
Location: Shrewsbury NJ, Washington D.C. DC, Wilmington NC,
Sponsor: Ambros Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07210515

Phase 3, Recruiting

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

for
PROC, Platinum Resistant Ovarian Cancer, Endometrial Cancer
Location: Long Island City NY, Philadelphia PA, Sarasota FL,
Sponsor: Whitehawk Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07470853

Phase 1, Recruiting

Popular cities in Arkansas

JonesboroLittle RockConwayFayettevilleFort Smith